PMID- 22168811 OWN - NLM STAT- MEDLINE DCOM- 20120716 LR - 20220318 IS - 1557-7600 (Electronic) IS - 1096-620X (Print) IS - 1096-620X (Linking) VI - 15 IP - 4 DP - 2012 Apr TI - Effects of natural eggshell membrane (NEM) on cytokine production in cultures of peripheral blood mononuclear cells: increased suppression of tumor necrosis factor-alpha levels after in vitro digestion. PG - 360-8 LID - 10.1089/jmf.2011.0197 [doi] AB - Tumor necrosis factor-alpha (TNF-alpha) plays an important role in inflammatory processes. This study examined the effects of natural eggshell membrane (NEM((R))) (ESM Technologies, LLC, Carthage, MO, USA) on interleukin (IL)-2, IL-4, IL-6, IL-10, interferon-gamma (IFN-gamma), and TNF-alpha cytokine production by 4-day peripheral blood mononuclear cell (PBMC) cultures exposed to serial dilutions of either an aqueous extract of natural eggshell membrane (NEM-AQ) or NEM subjected to in vitro digestion (NEM-IVD). The effects on cytokine production were also assessed in the presence of phytohemagglutinin (PHA) and pokeweed mitogen (PWM) where exposure to NEM-AQ resulted in reduced levels of proliferation and statistically significant effects on IL-6, IL-10, IFN-gamma, and TNF-alpha cytokine production. NEM-AQ reduced levels of IL-6, IL-10, IFN-gamma, and TNF-alpha in cultures exposed to PHA. In cultures containing PWM, NEM-AQ reduced production of IL-10 and at the highest dose tested increased IL-6 and decreased TNF-alpha cytokine levels. NEM-IVD, at the two lowest concentrations of product, significantly reduced TNF-alpha production by PBMC cultures exposed to PWM compared with the in vitro digest control or native NEM. Taken together, these results suggest that NEM-AQ can influence signaling events in response to the T cell-specific mitogen PHA as well as to the mitogen PWM that require cellular cross-talk and that these effects may be partially mediated through a reduction in level of the pro-inflammatory cytokine TNF-alpha. The suppression of TNF-alpha production in the presence of NEM-IVD is promising for the use of NEM as a consumable anti-inflammatory product. FAU - Benson, Kathleen F AU - Benson KF AD - NIS Labs , Klamath Falls, Oregon, USA. FAU - Ruff, Kevin J AU - Ruff KJ FAU - Jensen, Gitte S AU - Jensen GS LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20111214 PL - United States TA - J Med Food JT - Journal of medicinal food JID - 9812512 RN - 0 (Anti-Inflammatory Agents) RN - 0 (Immunologic Factors) RN - 0 (Interleukin-2) RN - 0 (Interleukin-6) RN - 0 (Phytohemagglutinins) RN - 0 (Tumor Necrosis Factor-alpha) RN - 130068-27-8 (Interleukin-10) RN - 207137-56-2 (Interleukin-4) RN - 82115-62-6 (Interferon-gamma) SB - IM MH - Adult MH - Animals MH - Anti-Inflammatory Agents/*pharmacology MH - Cell Proliferation MH - Cells, Cultured MH - Egg Shell/*chemistry MH - Electrophoresis, Polyacrylamide Gel MH - Humans MH - Immunologic Factors/*biosynthesis MH - Interferon-gamma/biosynthesis MH - Interleukin-10/biosynthesis MH - Interleukin-2/biosynthesis MH - Interleukin-4/biosynthesis MH - Interleukin-6/biosynthesis MH - Leukocytes, Mononuclear/*drug effects/*metabolism MH - Middle Aged MH - Phytohemagglutinins/pharmacology MH - Tumor Necrosis Factor-alpha/*antagonists & inhibitors/blood MH - Young Adult PMC - PMC3308710 EDAT- 2011/12/16 06:00 MHDA- 2012/07/17 06:00 PMCR- 2012/04/01 CRDT- 2011/12/16 06:00 PHST- 2011/12/16 06:00 [entrez] PHST- 2011/12/16 06:00 [pubmed] PHST- 2012/07/17 06:00 [medline] PHST- 2012/04/01 00:00 [pmc-release] AID - 10.1089/jmf.2011.0197 [pii] AID - 10.1089/jmf.2011.0197 [doi] PST - ppublish SO - J Med Food. 2012 Apr;15(4):360-8. doi: 10.1089/jmf.2011.0197. Epub 2011 Dec 14.